Taiwan is endemic for pyogenic liver abscess (PLA). Septic ocular or central nervous system (CNS) complications derived from PLA can result in catastrophic disability. We investigated the epidemiology and long-term prognosis of PLA patients with septic ocular or CNS complications over an 8-year period.
We extracted 21,307 patients with newly diagnosed PLA from a nationwide health registry in Taiwan between 2000 and 2007. The frequency of and risk factors for PLA with septic ocular or CNS complications were determined. The 2-year survival of these patients was compared between those with and without septic ocular or CNS complications. Septic ocular or CNS complications accounted for 2.1% of all PLA patients. Age and the Charlson comorbidity index were significantly lower in PLA patients with ocular or CNS complications than those without. Diabetes and age <65 years were independent predictors of septic ocular or CNS complications. The 2-year mortality of patients with septic ocular or CNS complications was similar to those without complications (24.8% vs. 27.5%, p = 0.502). However, among patients <65 years old and a Charlson index ≤1, the 2-year mortality was significantly higher in those with than without complications (18.6% vs. 11.8%, p = 0.001).
Citation: Lin Y-T, Liu C-J, Chen T-J, Fung C-P (2012) Long-Term Mortality of Patients with Septic Ocular or Central Nervous System Complications from Pyogenic Liver Abscess: A Population-Based Study. PLoS ONE 7(3): e33978. https://doi.org/10.1371/journal.pone.0033978
Editor: James A. Duce, The University of Melbourne, Australia
Received: December 21, 2011; Accepted: February 20, 2012; Published: March 27, 2012
Copyright: © 2012 Lin et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported partly by grants from Taipei Veterans General Hospital (V100D-002-3). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Pyogenic liver abscess (PLA) results from bacterial infection of the liver parenchyma, with subsequent infiltration by inflammatory cells and formation of pus. PLA is associated with significant morbidity, mortality, and health-care costs , . The disease is rare in Western countries, for example, the reported annual incidence rate was 2.3 per 100,000 population in Canada  1.0 per 100,000 population in Denmark , and 3.6 per 100,000 population in the United States . In Taiwan, however, the annual incidence of PLA has increased steadily from 11.2 per 100,000 population in 1996 to 17.6 per 100,000 population in 2004 . Reported case-fatality rates of PLA from population-based studies in Western countries are substantial, ranging from 5.6 to 19% –. According to a previous population-based study, the overall mortality rate of PLA in Taiwan was 10.9% .
Escherichia coli is the most common causative pathogen of PLA in most countries . However, in the past three decades, Klebsiella pneumoniae has emerged as the single leading cause of PLA in East Asian countries, especially in Taiwan –. A distinct syndrome of community-acquired pyogenic liver abscess, which is complicated by metastatic endophthalmitis or central nervous system (CNS) infections, has been reported since 1986, especially in patients with diabetes , , –. Despite aggressive therapy, the outcomes of these patients frequently involve catastrophic disability.
A previous study conducted in Taiwan has suggested that metastatic infection predicted mortality . However, another study from a different institute in Taiwan demonstrated a low mortality rate of PLA, even in patients with septic ocular or CNS complications, and suggested that the main concern was no longer mortality, but catastrophic disability due to irreversible ocular or neurological complications . Although Taiwan is endemic for PLA , population-based studies evaluating the epidemiology and the long-term outcomes of PLA with septic ocular or CNS complications have never been reported.
In the present study, we used a nationwide population-based database to investigate the frequency of, risk factors for, and long-term mortality of PLA with septic ocular or CNS complications over an 8-year period in Taiwan.
Materials and Methods
This study was based on data from the National Health Insurance (NHI) Research Database released by the National Health Research Institute. Taiwan began its National Health Insurance program in 1995 to finance health care for all of its residents. There are currently more than 25 million enrollees in the program, representing approximately 99% of Taiwan's entire population. The database includes comprehensive information on insured subjects, such as demographic data, dates of clinical visits, diagnostic codes, details of prescriptions, and expenditure amounts. International Classification of Diseases, Ninth Revision codes were used to define diseases during the study period. Laboratory data and microbiological data are not included. The highly trustworthy National Health Insurance Research Database has been used in the research of PLA published in peer-reviewed journals , . The dataset used in this study consists of de-identified secondary data released to the public for research purposes. This study was approved by the institutional review board of Taipei Veterans General Hospital. Since the identification numbers and personal information of all individuals were not included in the above secondary files to protect the privacy of the individuals, the review board approved that written consents from patients were not required.
In this retrospective cohort study, we identified 24,897 patients who had been hospitalized due to a diagnosis of liver abscess (ICD-9-CM diagnosis code 572.0) between January 1, 2000 to December 31, 2007. Amebic liver abscess (ICD-9-CM diagnosis code 006.3) was not included in this study because of its distinct features and etiologies. Patients with a past history of liver abscess prior to January 1, 2000 (n = 510), under the age of 18 years (n = 222), with underlying hepatobiliary malignancies or hepatobiliary malignancies diagnosed within 60 days (ICD-9-CM 155–156.9) (n = 2868) were excluded . The final sample included 21,297 patients. The underlying diseases and operative procedures, such as liver resection and drainage, were also collected for analysis. Comorbidities were recorded and used to obtain the Charlson comorbidity index , .
PLA patients with septic ocular complications were defined as PLA patients with purulent endophthalmitis (ICD-9-CM diagnosis code 360.0–360.04) or those receiving a vitrectomy (ICD-9-CM procedural codes 14.7–14.79) during the same admission. PLA patients with CNS complications were defined as PLA patients with meningitis (320–320.9 and 322.9) or a brain abscess (324–324.9 and 326) during the same admission.
Comparisons between groups were made using the χ2 test for categorical variables. All comparison tests were two-sided. Risk factors with P values less than 0.1 were entered into a multivariate analysis. A P value<0.05 was considered statistically significant. Survival curves were computed by the Kaplan–Meier method and were compared with a log-rank test. All statistical analyses were performed using SPSS statistical software version 17.0 for Windows (SPSS, Inc., Chicago, Illinois).
During the study period, a total of 21,297 patients with PLA were enrolled. Patients ranged in age from 18 to 101 years, with a median age of 61 years. A total of 8,959 (42.1%) patients had diabetes mellitus, 1,125 (5.3%) had cirrhosis of the liver, 4,484 (21.1%) had cholelithiasis, 1,315 (6.2%) had chronic obstructive pulmonary disease, 1,348 (6.3%) had chronic kidney disease, and 1,405 (6.6%) had extrahepatic malignancies. Male patients dominated the study population (13,104/21,307; 61.5%). The proportions of patients who received abscess drainage and surgical intervention were 28.5% and 11.6%, respectively. The 60-day mortality rate was 7.6%.
The number of identified PLA cases increased from 2,277 in 2000 to 2,911 in 2007 (Table 1). Among all of the patients with PLA, 453 (2.1%) had septic ocular or CNS complications. Specifically, 294 patients had an endogenous endophthalmitis, 176 patients had meningitis or a brain abscess, and 17 patients had both ocular and CNS complications. The annual frequency of PLA with septic ocular or CNS complications was not significantly different throughout the study period (p = 0.068) (Table 1).
The clinical characteristics of PLA patients with and without septic ocular or CNS complications are presented in Table 2. The 60-day mortality rate was not different between the two groups. PLA patients with septic ocular or CNS complications were more likely to be male (66.0% vs. 61.4%; p = 0.051) and younger (56.9±13.3 vs. 60.2±15.2 years; p<0.001) than patients without septic ocular or CNS complications. The Charlson comorbidity index was lower in PLA patients with ocular or CNS complications that without (1.1±1.4 vs. 1.5±1.9; p<0.001). In regards to underlying diseases, there were no significant differences between the two groups in underlying liver cirrhosis and cerebrovascular disease. The prevalence of diabetes was significantly higher among PLA patients with septic ocular or CNS complications (52.1% vs. 41.8%; p<0.001). Conversely, the prevalence of chronic renal disease (4.0% vs. 6.4%; p = 0.045), chronic obstructive pulmonary disease (2.9% vs. 6.2%; p = 0.003), cholelithiasis (6.6% vs. 21.4%; p<0.001), congestive heart failure (1.3% vs. 4.9%; p<0.001), and extrahepatic malignancies (3.8% vs. 6.7%; p = 0.016) was significantly lower among PLA patients with septic ocular or CNS complications.
A binary logistic regression was used to identify the independent risk factors for PLA with septic ocular or CNS complications. Diabetes (odds ratio [OR] = 1.46, 95% CI = 1.21–1.76, P<0.001), and age <65 years (OR = 1.51, 95% CI = 1.23–1.86, p<0.001) were independent predictors of septic ocular or CNS complications among all PLA patients. Extrahepatic cancer (OR = 0.61, 95% CI = 0.37–0.99, p = 0.047), cholelithiasis (OR = 0.29, 95% CI = 0.20–0.43, p<0.001), and congestive heart failure (OR = 0.31, 95% CI = 0.14–0.71, p = 0.005) were associated with a lower risk of septic ocular or CNS complications in PLA patients.
The Kaplan-Meier survival curves of PLA patients with and without septic ocular or CNS complications are presented in Figure 1. There was no significant difference in the 2-year mortality between PLA patients with and without septic ocular or CNS complications (24.8% vs. 27.5%, p = 0.502, by log-rank test). We further selected PLA patients <65 years old and a Charlson comorbidity ≤1 (i.e. between 0 and 1) for further comparison (249 patients with complications and 9082 without complications), and the 2-year mortality was significantly higher among PLA patients with septic ocular or CNS complications than those without (18.6% vs. 11.8%, p = 0.001, by log-rank test) (Figure 2).
The present study is a first ever nationwide population-based study to report on the epidemiology and long-term outcomes of PLA with septic ocular or CNS complications in Taiwan. The strengths of the present study are that it is based on a large nationwide population-based sample, contains data on a wide variety of demographic characteristics, and has a complete history of the medical service used by the sampled patients. We found that 2.1% of all PLA cases presented with septic ocular or CNS complications. It should be noted that the annual frequency of septic ocular or CNS complications was relatively steady throughout the study period. Although management of PLA has improved in Taiwan due to increased physician awareness , it is still likely that complications arise at the time of presentation, and thereby, are not preventable, regardless of the antibiotic treatment used . Therefore, it is essential for physicians to maintain high clinical vigilance for the development of these metastatic infections through early detection and management of high-risk patients in the endemic region.
Investigations comparing the clinical features of PLA patients with and without septic ocular or CNS complications have been rarely reported . The risk factors for septic metastatic infections include the virulence factors of K. pneumoniae  and host factors, such as diabetes . The current nationwide population-based study focused on host factors and demonstrated that individuals with diabetes and an age <65 years are predisposed to metastatic infection via multivariate analysis. The concept that younger individuals are more susceptible to metastatic infection has never been reported, in part, due to the small sample sizes of patients in the literature , , . As for other demographic data, extrahepatic cancer, cholelithiasis, and congestive heart failure were all associated with a lower risk of septic ocular or CNS complications. All of these findings suggest that septic ocular or CNS complications are more likely to develop in younger and diabetic, but otherwise healthy, patients.
In one previous study, 70% of patients with septic ocular or CNS complications experienced irreversible catastrophic disability, including loss of vision in the affected eye(s), quadriplegia, paraparesis, or impaired higher cortical function . Poor visual outcomes, despite aggressive management, were also documented , , . However, the long-term mortality of patients with septic ocular or CNS complications has not yet been investigated. The short-term mortality (i.e. 60-day) was slightly higher in PLA patients with septic ocular or CNS complications, however not statistically significant (9.1% vs. 7.5%; p = 0.241). It may be reasonable to suggest that the infectious process per se was the dominant cause of short-term mortality. However, irreversible catastrophic disability from septic ocular or CNS complications may lead to mortality in a few months to years later. Recognizing the potential for adverse long-term outcomes is important, as the findings from previous studies that evaluated only the short-term mortality likely underestimated the true burden of the illnesses associated with PLA.
It is well-known that co-morbid illnesses and age have an important influence on long-term mortality of infectious diseases , . The older age and co-morbidities may contribute to the long-term mortality significantly in PLA patients without septic ocular or CNS complications. Although PLA patients with complications were younger and had a lower Charlson cormobidity index than those without complications, the complications may lead to the similar long-term outcome between the 2 groups. The long-term mortality following infection may be attributable to a combination of pre-existing co-morbidities, the nature and severity of the initial infection, and the direct complications arising from this acute disease. Given the lower number of co-morbidities and the slightly higher short-term mortality, the long-term mortality of PLA patients with septic ocular or CNS complications may be attributed to irreversible catastrophic disability. To clarify the poor long-term prognosis of PLA patients with septic ocular or CNS complications, PLA patients <65 years old and a Charlson comorbidity index ≤1 were selected for further analysis. The result demonstrated that these patients have a lower 2-year survival than those without septic ocular or CNS complications. Thus, physicians should be informed about the distinct clinical group of PLA patients that are younger and have less co-morbidities, and simultaneously carry a poor long-term prognosis.
This study suffers from several limitations. First, the study does not have microbiological data, however, it is well established that K. pneumoniae is the major etiological factor of PLA in Taiwan, and is exclusively responsible for septic ocular or CNS complications . Second, detailed clinical variables, including clinical manifestations and laboratory findings, were not available. Consequently, we were not able to directly assess the relationship between the severity of disease and long-term mortality. Lastly, we did not include quality of life measurement, which are important markers of long-term outcome following PLA.
In conclusion, this study provides a clear picture of with respect to the disease burden of PLA with septic ocular and CNS complications in Taiwan. Our findings indicate that septic ocular or CNS complications accounts for 2.1% of PLA patients in Taiwan. Septic ocular or CNS complications are more likely to develop in younger and diabetic, but otherwise healthy, patients. Physicians should recognize that catastrophic disability due to ocular or neurological complications from PLA could lead to a poorer long-term prognosis, and thereby, follow up these patients more closely. A comprehensive and collaborative management of PLA via the combined efforts of multiple medical subspecialties is necessary to tackle this problem in the future.
This study is based in part on data from the NHRID provided by the Bureau of National Health Insurance, Department of Health, and managed by National Health Research Institutes. The interpretation and conclusions contained herein do not represent those of Bureau of National Health Insurance, Department of Health or National Health Research Institutes.
Conceived and designed the experiments: YTL. Performed the experiments: CJL. Analyzed the data: YTL CJL. Contributed reagents/materials/analysis tools: TJC. Wrote the paper: YTL CPF. Supervised the study: CPF.
- 1. Kaplan GG, Gregson DB, Laupland KB (2004) Population-based study of the epidemiology of and the risk factors for pyogenic liver abscess. Clin Gastroenterol Hepatol 2: 1032–1038.
- 2. Meddings L, Myers RP, Hubbard J, Shaheen AA, Laupland KB, et al. (2010) A population-based study of pyogenic liver abscesses in the United States: incidence, mortality, and temporal trends. Am J Gastroenterol 105: 117–124.
- 3. Jepsen P, Vilstrup H, Schønheyder HC, Sørensen HT (2005) A nationwide study of the incidence and 30-day mortality rate of pyogenic liver abscess in Denmark, 1977–2002. Aliment Pharmacol Ther 21: 1185–1188.
- 4. Tsai FC, Huang YT, Chang LY, Wang JT (2008) Pyogenic liver abscess as endemic disease, Taiwan. Emerg Infect Dis 14: 1592–1600.
- 5. Lederman ER, Crum NF (2005) Pyogenic liver abscess with a focus on Klebsiella pneumoniae as a primary pathogen: an emerging disease with unique clinical characteristics. Am J Gastroenterol 100: 322–331.
- 6. Cheng DL, Liu YC, Yen MY, Liu CY, Wang RS (1991) Septic metastatic lesions of pyogenic liver abscess. Their association with Klebsiella pneumoniae bacteremia in diabetic patients. Arch Intern Med 151: 1557–1559.
- 7. Wang JH, Liu YC, Lee SS, Yen MY, Chen YS, et al. (1998) Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clin Infect Dis 26: 1434–1438.
- 8. Fung CP, Chang FY, Lee SC, Hu BS, Kuo BI, et al. (2002) A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis? Gut 50: 420–424.
- 9. Ko WC, Paterson DL, Sagnimeni AJ, Hansen DS, Von Gottberg A, et al. (2002) Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis 8: 160–166.
- 10. Chung DR, Lee SS, Lee HR, Kim HB, Choi HJ, et al. (2007) Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea. J Infect 54: 578–583.
- 11. Fang CT, Lai SY, Yi WC, Hsueh PR, Liu KL, et al. (2007) Klebsiella pneumoniae genotype K1: an emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess. Clin Infect Dis 45: 284–293.
- 12. Yeh KM, Kurup A, Siu LK, Koh YL, Fung CP, et al. (2007) Capsular serotype K1 or K2, rather than magA and rmpA, is a major virulence determinant for Klebsiella pneumoniae liver abscess in Singapore and Taiwan. J Clin Microbiol 45: 466–471.
- 13. Lok KH, Li KF, Li KK, Szeto ML (2008) Pyogenic liver abscess: clinical profile, microbiological characteristics, and management in a Hong Kong hospital. J Microbiol Immunol Infect 41: 483–490.
- 14. Liu YC, Cheng DL, Lin CL (1986) Klebsiella pneumoniae liver abscess associated with septic endophthalmitis. Arch Intern Med 146: 1913–1916.
- 15. Chou FF, Kou HK (1996) Endogenous endophthalmitis associated with pyogenic hepatic abscess. J Am Coll Surg 182: 33–36.
- 16. Yang CS, Tsai HY, Sung CS, Lin KH, Lee FL, et al. (2007) Endogenous Klebsiella endophthalmitis associated with pyogenic liver Abscess. Ophthalmology 114: 876–880.
- 17. Lee SS, Chen YS, Tsai HC, Wann SR, Lin HH, et al. (2008) Predictors of septic metastatic infection and mortality among patients with Klebsiella pneumoniae liver abscess. Clin Infect Dis 47: 642–650.
- 18. Sheu SJ, Kung YH, Wu TT, Chang FP, Horng YH (2011) Risk factors for endogenous endophthalmitis secondary to Klebsiella pneumoniae liver abscess: 20-year experience in southern Taiwan. Retina 31: 2026–2031.
- 19. Tan YM, Chee SP, Soo KC, Chow P (2004) Ocular manifestations and complications of pyogenic liver abscess. World J Surg 28: 38–42.
- 20. Lin YT, Liu CJ, Chen TJ, Chen TL, Yeh YC, et al. (2011) Pyogenic liver abscess as the initial manefestation of underlying hepatocellular carcinoma. Am J Med 124: 1158–1164.
- 21. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373–383.
- 22. Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45: 613–619.
- 23. Al-Mahmood A, Al-Binali G, AlKatan H, Abboud E, Abu El-Asrar A (2011) Endogenous endophthalmitis associated with liver abscess caused by Klebsiella pneumoniae. Int Ophthalmol 31: 145–148.
- 24. Laupland KB, Svenson LW, Gregson DB, Church DL (2011) Long-term mortality associated with community-onset bloodstream infection. Infection 39: 405–410.
- 25. Leibovici L, Samra Z, Konigsberger H, Drucker M, Ashkenazi S, et al. (1995) Long-term survival following bacteremia or fungemia. JAMA 274: 807–812.